Karen Kirby
Family · Moulton, ALNPI 1023000635
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $748 and has fallen 96.9% since, to $23 in 2024.
Across 116 payments — averaging $14.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$341
- Abbott$257
- Lilly USA, LLC$157
- Otsuka America Pharmaceutical, Inc.$132
- AstraZeneca$109
- Kowa Pharmaceuticals America, Inc.$87
- plus $550 from 17 others
What the payments were for
- Food & beverage$1,633100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $341 |
| Abbott | 12 | $257 |
| Lilly USA, LLC | 9 | $157 |
| Otsuka America Pharmaceutical, Inc. | 10 | $132 |
| AstraZeneca | 7 | $109 |
| Kowa Pharmaceuticals America, Inc. | 7 | $87 |
| Amarin Pharma, Inc. | 4 | $72 |
| Amgen | 4 | $65 |
| Pfizer | 4 | $63 |
| Bayer | 4 | $63 |
| Boehringer Ingelheim | 4 | $60 |
| Novartis | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Indivior Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Exact Sciences | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,633 in reported general payments places this provider in the 70th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 11 | $952 |
| Doxycycline Hyclate | 88 | $768 |
| Fluticasone Propionate | 66 | $690 |
| NitrofurantoinNitrofurantoin Macrocrystal | 13 | $445 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $353 |
| Azithromycin | 35 | $138 |
| Prednisone | 12 | $78 |
Paid to pharmacies, not to this prescriber.
Other family in Moulton
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
- Brandy YoungMontgomery$27K
- Julia BettsHuntsville$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.